Source: BioPharma Dive

Exsilio Solutions: Exsilio debuts with $82M, pitching a 'leap' forward for genetic medicine

The company claims it can address some of the field's limitations with medicines delivered via messenger RNA and lipid nanoparticles.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more